drug

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DIETARY_SUPPLEMENT
Pre-approval / investigational in the US
Developed by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DIETARY_SUPPLEMENT

Indications

Trials

1
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS
NCT06426134—Completed

KOLs & investigators

1
Karin Huizer, MD/PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
company
trial
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS
NA
trial
indication
Schizophrenia
indication
Psychosis
indication
Schizophrenia and Related Disorders
indication
Depressive Episode
indication
KOL
Karin Huizer, MD/PhD
KOL score —
person